Five Star Equities Provides Stock Research on The Dow Chemical Company and Leggett & Platt
Continue ReadingTag: equity-research
Special Dividend Payments in 2012 Are Four Times the Amount Seen in 2011
Five Star Equities Provides Stock Research on Abbott Laboratories and Tellabs
Continue Reading
U.S. Banks Post Best Quarter Since the Financial Crisis
The Paragon Report Provides Stock Research on Fifth Third Bancorp and Regions Financial
Continue Reading
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Celldex Therapeutics and Neostem
Continue Reading
Copper Demand Expected to Exceed Supply in the First Half of 2013
The Paragon Report Provides Stock Research on Sterlite Industries and Thompson Creek Metals
Continue Reading
Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms
Five Star Equities Provides Stock Research on Bristol Myers Squibb and Pfizer
Continue Reading
Banking Industry on Pace to Best Broader Markets in 2012
The Paragon Report Provides Stock Research on SunTrust Banks and U.S. Bancorp
Continue Reading
Amount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011
Five Star Equities Provides Stock Research on Ameren and Pepco Holdings
Continue Reading
Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
Five Star Equities Provides Stock Research on Neuralstem and Cyclacel Pharmaceuticals
Continue Reading
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on StemCells and Aastrom Biosciences
Continue Reading